Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04249700 · ClinicalTrials.gov registry record · NA
Investigating the Effect of Single-session Sauna Use on Body Temperature
A NA study of Core Body Temperature 101.3 F, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT04249700: Completed NA study of Core Body Temperature 101.3 F, sponsored by University of California, San Francisco.
NCT04249700 is a NA study of Core Body Temperature 101.3 F that has completed, run by University of California, San Francisco. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04249700, a NA study of Core Body Temperature 101.3 F, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Whole-body hyperthermia (WBH) to an internal temperature of 38.5 C (101.3 F) using an infrared heating device has been associated with significant reductions in clinical depression. This prior work utilized a WBH medical device that is manufactured in Germany, is not FDA approved, and is not widely available. The goal of this initial pilot project is to ascertain whether an infrared sauna, the Curve Sauna Dome, which is readily accessible (i.e., can be purchased by consumers in the US) can be used to conduct WBH that achieves an internal body temperature of of 101.3 F in healthy volunteers.
Primary Outcome
Achieving core body temperature of 101.3 F using a rectal temperature assessment method
Conditions Studied
Interventions
- DEVICE Curve Sauna Dome
Study Locations (1)
California
- University of California San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-09-13 |
| Est. Completion | 2020-04-01 |
| Phase | NA |
What the finished NCT04249700 record still lists
NCT04249700 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Core Body Temperature 101.3 F appearing as the primary indexed condition, and to 1 intervention - of which Curve Sauna Dome is the first listed.
NCT04249700 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04249700 about?
NCT04249700 is a clinical study titled "Investigating the Effect of Single-session Sauna Use on Body Temperature". Whole-body hyperthermia (WBH) to an internal temperature of 38.5 C (101.3 F) using an infrared heating device has been associated with significant reductions in clinical depression. This prior work utilized a WBH medical device that is manufactured in Germany, is not FDA approved, and is not widely ...
What is the current status of trial NCT04249700?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2019-09-13. Estimated completion is 2020-04-01.
What conditions does trial NCT04249700 study?
This clinical trial studies the following conditions: Core Body Temperature 101.3 F.
What interventions are being tested in trial NCT04249700?
The interventions under investigation include: Curve Sauna Dome (DEVICE).
Who is sponsoring clinical trial NCT04249700?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04249700 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04249700's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI